SARS-CoV-2 re-infection: development of an epidemiological definition from India

被引:27
|
作者
Mukherjee, Aparna [1 ]
Anand, Tanu [1 ]
Agarwal, Anup [1 ]
Singh, Harpreet [2 ]
Chatterjee, Pranab [3 ]
Narayan, Jitendra [1 ]
Rana, Salaj [1 ]
Gupta, Nivedita [1 ]
Bhargava, Balram [4 ]
Panda, Samiran [1 ]
机构
[1] ICMR Headquarters, Div Epidemiol & Communicable Dis, Delhi, India
[2] ICMR Headquarters, Div Informat Syst & Res Management, Delhi, India
[3] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
[4] ICMR Headquarters, Delhi, India
关键词
COVID-19; re-infection; viable virus; viral shedding;
D O I
10.1017/S0950268821000662
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The current investigation was conducted with the objective to develop an epidemiological case definition of possible severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) re-infection and assess its magnitude in India. The epidemiological case definition for SARS-CoV-2 re-infection was developed from literature review of data on viral kinetics. For achieving second objective, the individuals who satisfied the developed case definition for SARS-CoV-2 re-infection were contacted telephonically. Taking available evidence into consideration, re-infection with SARS-CoV-2 in our study was defined as any individual who tested positive for SARS-CoV-2 on two separate occasions by either molecular tests or rapid antigen test at an interval of at least 102 days with one negative molecular test in between. In this archive based, telephonic survey, 58 out of 1300 individuals (4.5%) fulfilled the above-mentioned definition; 38 individuals could be contacted with healthcare workers (HCWs) accounting for 31.6% of the cases. A large proportion of participants was asymptomatic and had higher Ct value during the first episode. While SARS-CoV-2 re-infection is still a rare phenomenon, there is a need for epidemiological definition of re-infection for establishing surveillance systems and this study contributes to such a goal. Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) re-infection is an emerging concern and there is a need to define it. Therefore, working epidemiological case definition for re-infection was developed and its magnitude was explored via archive-based, telephonic survey. Re-infection with SARS-CoV-2 was defined as two positive tests at an interval of at least 102 days with one interim negative test. Thirty-eight of the 58 eligible patients could be contacted with 12 (31.6%) being HCWs. Majority of the participants were asymptomatic and had higher Ct value during their first episode. To conclude, a working epidemiological case definition of SARS-CoV-2 re-infection is important to strengthen surveillance. The present investigation contributes to this goal and records reinfection in 4.5% of SARS-CoV-2 infected individuals in India.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Role of Metals on SARS-CoV-2 Infection: a Review of Recent Epidemiological Studies
    Khan, Khalid M.
    Zimpfer, Mariah J.
    Sultana, Rasheda
    Parvez, Tahmid M.
    Navas-Acien, Ana
    Parvez, Faruque
    CURRENT ENVIRONMENTAL HEALTH REPORTS, 2023, 10 (04) : 353 - 368
  • [32] Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines
    Hromic-Jahjefendic, Altijana
    Lundstrom, Kenneth
    Adilovic, Muhamed
    Aljabali, Alaa A. A.
    Tambuwala, Murtaza M.
    Serrano-Aroca, Angel
    Uversky, Vladimir N.
    AUTOIMMUNITY REVIEWS, 2024, 23 (03)
  • [33] Incidence of SARS-CoV-2 re-infection in anti-nucleocapsid IgG-positive healthcare workers: a prospective cohort study
    Saima Mehboob
    Asif Rehman
    Mohsina Haq
    Hala Rajab
    Momina Haq
    Hala Haq
    Jawad Ahmad
    Sajjad Ahmad
    Mohammed Abbas
    Saeed Anwar
    NajibUl Haq
    Irish Journal of Medical Science (1971 -), 2023, 192 : 915 - 918
  • [34] Incidence of SARS-CoV-2 re-infection in anti-nucleocapsid IgG-positive healthcare workers: a prospective cohort study
    Mehboob, Saima
    Rehman, Asif
    Haq, Mohsina
    Rajab, Hala
    Haq, Momina
    Haq, Hala
    Ahmad, Jawad
    Ahmad, Sajjad
    Abbas, Mohammed
    Anwar, Saeed
    Haq, NajibUl
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (02) : 915 - 918
  • [35] The Immunopathobiology of SARS-CoV-2 Infection
    Patel, Milankumar
    Shahjin, Farah
    Cohen, Jacob D.
    Hasan, Mahmudul
    Machhi, Jatin
    Chugh, Heerak
    Singh, Snigdha
    Das, Srijanee
    Kulkarni, Tanmay A.
    Herskovitz, Jonathan
    Meigs, Douglas D.
    Chandra, Ramesh
    Hettie, Kenneth S.
    Mosley, R. Lee
    Kevadiya, Bhavesh D.
    Gendelman, Howard E.
    FEMS MICROBIOLOGY REVIEWS, 2021, 45 (06)
  • [36] SARS-CoV-2 Infection and the Newborn
    Ovali, Fahri
    FRONTIERS IN PEDIATRICS, 2020, 8
  • [37] Epitranscriptomics of SARS-CoV-2 Infection
    Izadpanah, Amin
    Rappaport, Jay
    Datta, Prasun K.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [38] Intussusception and SARS-CoV-2 infection
    Mercado-Martinez, Israel
    Javier Arreaga-Gutierrez, Francisco
    Natalia Pedraza-Pena, Andrea
    JOURNAL OF PEDIATRIC SURGERY CASE REPORTS, 2021, 67
  • [39] SARS-CoV-2 Infection and the Liver
    Morgan, Katie
    Samuel, Kay
    Vandeputte, Martin
    Hayes, Peter C.
    Plevris, John N.
    PATHOGENS, 2020, 9 (06):
  • [40] Neuroimmunoendocrinology of SARS-CoV-2 Infection
    Bellastella, Giuseppe
    Cirillo, Paolo
    Carbone, Carla
    Scappaticcio, Lorenzo
    Maio, Antonietta
    Botta, Graziella
    Tomasuolo, Maria
    Longo, Miriam
    Pontillo, Alessandro
    Bellastella, Antonio
    Esposito, Katherine
    De Bellis, Annamaria
    BIOMEDICINES, 2022, 10 (11)